Yes, I won't fill it up either. However, I do think this is associated with the topic.
In the past, I have had some familiarity with audits / Inspections wrt pharmaceuticals. GMP and GxP. You are correct that I misunderstood that the audits being carried out on the unapproved labs the Irish state used for cervical screening were only checks in relation to false negatives and cancers subsequently diagnosed. This raises more questions really.
If, as you say, audits are necessary to maintain standards, then why was the decision made to suspend them?
Is it know how many women were kept in the dark about the false negatives of their screening results? This article states that thousands of women could have been involved. Why and who decided to keep them in the dark?
www.irishexaminer.com/news/arid-20470157.html
Why were unapproved labs used and how often were they Inspected?
Why did Irish officials fail to keep track of the labs and why did Irish officials have an “inadequate” system for responding to screening errors, as per the Scally Report?
What has been done to address this? What is intended to be done to address anything that hasn't been improved?
Not posing these questions at you, Lizzy. Even though you do seem to have some familiarity with it. Just a few Q's off the top of my head. Pondering really. I am sure there must have been much come to light in the Scally report as it seems to be quite excoriating. Particularly mentioning dysfunction, unaccountability and misogyny.
Maybe not such a far journey to exclude the mention of women from the cancer screening of a body part only found in women.